Class information for:
Level 1: CMV PREVENTION//TRANSFUSION ASSOCIATED INFECTION//ACUTE EBV INFECTION VZV SPECIFIC IGA

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
18635 542 26.5 47%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY 1353914
220 3       CYTOMEGALOVIRUS//VIROLOGY//JOURNAL OF VIROLOGY 50388
429 2             CYTOMEGALOVIRUS//HUMAN CYTOMEGALOVIRUS//HUMAN HERPESVIRUS 6 16394
18635 1                   CMV PREVENTION//TRANSFUSION ASSOCIATED INFECTION//ACUTE EBV INFECTION VZV SPECIFIC IGA 542

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CMV PREVENTION authKW 75115 0% 67% 2
2 TRANSFUSION ASSOCIATED INFECTION authKW 75115 0% 67% 2
3 ACUTE EBV INFECTION VZV SPECIFIC IGA authKW 56337 0% 100% 1
4 AKH EBENE 4I address 56337 0% 100% 1
5 CELLULAR SOS MECHANISMS authKW 56337 0% 100% 1
6 CHAIR WORKING GRP AGANIST TRANSFUS TRANSMITTED DI address 56337 0% 100% 1
7 CMV SEROPREVALENCE authKW 56337 0% 100% 1
8 COCUK SAGLIGI HASTALIKLANRI ANABILIM DALI address 56337 0% 100% 1
9 CRPH authKW 56337 0% 100% 1
10 CYTOMEGALOVIRUS ANTIBODIES authKW 56337 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Virology 3698 20% 0% 109
2 Hematology 2168 20% 0% 107
3 Microbiology 1034 19% 0% 104
4 Immunology 756 19% 0% 104
5 Infectious Diseases 304 8% 0% 42
6 Pathology 261 7% 0% 37
7 Biochemical Research Methods 172 7% 0% 37
8 Medical Laboratory Technology 165 3% 0% 17
9 Medicine, General & Internal 120 8% 0% 46
10 Biotechnology & Applied Microbiology 54 6% 0% 31

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AKH EBENE 4I 56337 0% 100% 1
2 CHAIR WORKING GRP AGANIST TRANSFUS TRANSMITTED DI 56337 0% 100% 1
3 COCUK SAGLIGI HASTALIKLANRI ANABILIM DALI 56337 0% 100% 1
4 EUROPEO 56337 0% 100% 1
5 FRIEDRICH LOFFLER MED MIKROBIOL 56337 0% 100% 1
6 KLIN BAKTERIYOL ENFEK HASTALIKLARI ANABILIN DAL 56337 0% 100% 1
7 KLIN INNERE MED HAEMATOL ONKOL C 56337 0% 100% 1
8 KLIN ODDELEK HEMATOL INTERNE KLIN 56337 0% 100% 1
9 KLIN ODDELEK OTROSKO KIRURGIJO INTENZ TER IJO 56337 0% 100% 1
10 MIDATLANT REG 56337 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TRANSFUSION 12350 8% 1% 41
2 JOURNAL OF MEDICAL VIROLOGY 6637 6% 0% 30
3 COMPREHENSIVE IMMUNOLOGY 5120 0% 9% 1
4 JOURNAL OF VIROLOGICAL METHODS 5018 5% 0% 25
5 JOURNAL OF CLINICAL MICROBIOLOGY 4874 9% 0% 48
6 ACTA VIROLOGICA 3945 2% 1% 12
7 TRANSFUSION MEDICINE REVIEWS 3616 1% 1% 6
8 ACTA MICROBIOLOGICA POLONICA 2575 1% 1% 4
9 REVISTA DOYMA DE INMUNOLOGIA 2559 0% 5% 1
10 VOPROSY VIRUSOLOGII 2488 2% 0% 10

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CMV PREVENTION 75115 0% 67% 2 Search CMV+PREVENTION Search CMV+PREVENTION
2 TRANSFUSION ASSOCIATED INFECTION 75115 0% 67% 2 Search TRANSFUSION+ASSOCIATED+INFECTION Search TRANSFUSION+ASSOCIATED+INFECTION
3 ACUTE EBV INFECTION VZV SPECIFIC IGA 56337 0% 100% 1 Search ACUTE+EBV+INFECTION+VZV+SPECIFIC+IGA Search ACUTE+EBV+INFECTION+VZV+SPECIFIC+IGA
4 CELLULAR SOS MECHANISMS 56337 0% 100% 1 Search CELLULAR+SOS+MECHANISMS Search CELLULAR+SOS+MECHANISMS
5 CMV SEROPREVALENCE 56337 0% 100% 1 Search CMV+SEROPREVALENCE Search CMV+SEROPREVALENCE
6 CRPH 56337 0% 100% 1 Search CRPH Search CRPH
7 CYTOMEGALOVIRUS ANTIBODIES 56337 0% 100% 1 Search CYTOMEGALOVIRUS+ANTIBODIES Search CYTOMEGALOVIRUS+ANTIBODIES
8 CYTOMEGALOVIRUS ANTIBODY 56337 0% 100% 1 Search CYTOMEGALOVIRUS+ANTIBODY Search CYTOMEGALOVIRUS+ANTIBODY
9 CYTOMEGALOVIRUS SEROCONVERSION 56337 0% 100% 1 Search CYTOMEGALOVIRUS+SEROCONVERSION Search CYTOMEGALOVIRUS+SEROCONVERSION
10 FILTERED BLOOD COMPONENTS 56337 0% 100% 1 Search FILTERED+BLOOD+COMPONENTS Search FILTERED+BLOOD+COMPONENTS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 SEED, CR , WONG, J , POLIZZOTTO, MN , FADDY, H , KELLER, AJ , PINK, J , (2015) THE RESIDUAL RISK OF TRANSFUSION-TRANSMITTED CYTOMEGALOVIRUS INFECTION ASSOCIATED WITH LEUCODEPLETED BLOOD COMPONENTS.VOX SANGUINIS. VOL. 109. ISSUE 1. P. 11 -17 20 83% 3
2 WU, YY , ZOU, SM , CABLE, R , DORSEY, K , TANG, YL , HAPIP, CA , MELMED, R , TROUERN-TREND, J , WANG, JH , CHAMPION, M , ET AL (2010) DIRECT ASSESSMENT OF CYTOMEGALOVIRUS TRANSFUSION-TRANSMITTED RISKS AFTER UNIVERSAL LEUKOREDUCTION.TRANSFUSION. VOL. 50. ISSUE 4. P. 776 -786 23 74% 23
3 HEDDLE, NM , BOECKH, M , GROSSMAN, B , JACOBSON, J , KLEINMAN, S , TOBIAN, AAR , WEBERT, K , WONG, ECC , ROBACK, JD , (2016) AABB COMMITTEE REPORT: REDUCING TRANSFUSION-TRANSMITTED CYTOMEGALOVIRUS INFECTIONS.TRANSFUSION. VOL. 56. ISSUE 6. P. 1581 -1587 20 63% 2
4 MAINOU, M , ALAHDAB, F , TOBIAN, AAR , ASI, N , MOHAMMED, K , MURAD, MH , GROSSMAN, BJ , (2016) REDUCING THE RISK OF TRANSFUSION-TRANSMITTED CYTOMEGALOVIRUS INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS.TRANSFUSION. VOL. 56. ISSUE 6. P. 1569 -1580 14 78% 3
5 VAMVAKAS, EC , (2005) IS WHITE BLOOD CELL REDUCTION EQUIVALENT TO ANTIBODY SCREENING IN PREVENTING TRANSMISSION OF CYTOMEGALOVIRUS BY TRANSFUSION? A REVIEW OF THE LITERATURE AND META-ANALYSIS.TRANSFUSION MEDICINE REVIEWS. VOL. 19. ISSUE 3. P. 181-199 23 68% 61
6 DELANEY, M , MAYOCK, D , KNEZEVIC, A , NORBY-SLYCORD, C , KLEINE, E , PATEL, R , EASLEY, K , JOSEPHSON, C , (2016) POSTNATAL CYTOMEGALOVIRUS INFECTION: A PILOT COMPARATIVE EFFECTIVENESS STUDY OF TRANSFUSION SAFETY USING LEUKOREDUCED-ONLY TRANSFUSION STRATEGY.TRANSFUSION. VOL. 56. ISSUE 8. P. 1945 -1950 14 82% 1
7 ZIEMANN, M , HENNIG, H , (2014) PREVENTION OF TRANSFUSION-TRANSMITTED CYTOMEGALOVIRUS INFECTIONS: WHICH IS THE OPTIMAL STRATEGY?.TRANSFUSION MEDICINE AND HEMOTHERAPY. VOL. 41. ISSUE 1. P. 40-44 16 73% 11
8 PREIKSAITIS, JK , (2000) THE CYTOMEGALOVIRUS-"SAFE" BLOOD PRODUCT: IS LEUKOREDUCTION EQUIVALENT TO ANTIBODY SCREENING?.TRANSFUSION MEDICINE REVIEWS. VOL. 14. ISSUE 2. P. 112 -136 46 36% 24
9 ROBACK, JD , (2002) CMV AND BLOOD TRANSFUSIONS.REVIEWS IN MEDICAL VIROLOGY. VOL. 12. ISSUE 4. P. 211 -219 32 48% 35
10 VOLLMER, T , KNABBE, C , DREIER, J , (2015) SYSTEMATIC EVALUATION OF DIFFERENT NUCLEIC ACID AMPLIFICATION ASSAYS FOR CYTOMEGALOVIRUS DETECTION: FEASIBILITY OF BLOOD DONOR SCREENING.JOURNAL OF CLINICAL MICROBIOLOGY. VOL. 53. ISSUE 10. P. 3219 -3225 16 70% 0

Classes with closest relation at Level 1


Rank Class id link
1 4155 CONGENITAL INFECTION//CYTOMEGALOVIRUS//CONGENITAL CYTOMEGALOVIRUS INFECTION
2 405 CYTOMEGALOVIRUS//VALGANCICLOVIR//PREEMPTIVE THERAPY
3 6563 LEUKOREDUCTION//BLOOD TRANSFUSION//LEUCODEPLETION
4 786 HUMAN CYTOMEGALOVIRUS//HCMV//VIROLOGY
5 20030 TZANCK SMEAR//ACCELLON SAMPLING//AGIZ HASTALIKLARI BIRIMI
6 20268 TA GVHD//TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE//POST TRANSFUSION GRAFT VERSUS HOST DISEASE
7 37268 MENGO VIRUS INFECTION//PHYSIOLOGICAL INTERFERON//VIRAL VACCINE ASSAY
8 31213 POLYLYS PHE//IMMUNOGLOBULIN MEASUREMENT//ANTI AMEBIC ANTIBODIES
9 4997 RUBELLA//CONGENITAL RUBELLA SYNDROME//RUBELLA VIRUS
10 11559 INFECTIOUS MONONUCLEOSIS//EPSTEIN BARR VIRUS//MONONUCLEOSIS

Go to start page